FTC Issues New HSR Thresholds
Client Alert | 1 min read | 01.16.07
Today the Federal Trade Commission released its annual revisions to the jurisdictional and filing fee thresholds applicable under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”). The dollar thresholds of the HSR Act and Rules are indexed on an annual basis, based on changes in the U.S. gross national product. As a result of these changes, the size-of-transaction threshold will increase from $56.7 million to $59.8 million. In addition, the size-of-parties thresholds, the filing fee thresholds and the thresholds applicable to certain exemptions will also increase. These revisions will become effective thirty days after their publication in the Federal Register.
To read a full copy of the Commission's announcement, including all of the revised thresholds, click here
Insights
Client Alert | 2 min read | 05.09.25
FDA Seeks Stakeholder Consultation on Prescription Drug User Fee Reauthorization
On May 8, the U.S. Food and Drug Administration (FDA) took steps to begin the process for reauthorizing the Prescription Drug User Fee Amendments (PDUFA) by announcing a public meeting to be held on July 14, 2025. The agency invited public stakeholders, including patient and consumer advocate groups, health care professionals, and scientific and academic experts to participate in the meeting and subsequent public meetings to consult on the PDUFA reauthorization.
Client Alert | 2 min read | 05.09.25
New SF-328 for Foreign Ownership, Control, and Influence Assessments Approved, Publication Imminent
Client Alert | 4 min read | 05.08.25
Client Alert | 4 min read | 05.07.25
